{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T05:24:04Z","timestamp":1788413044998,"version":"build-2803163510"},"reference-count":15,"publisher":"Mark Allen Group","issue":"Sup9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Community Nurs"],"published-print":{"date-parts":[[2026,9,1]]},"abstract":"<jats:p>The NHS Fit for the Future 10 Year Health Plan published in July 2025, represents the most ambitious structural redesign of the health service for a generation. For wound care, this creates both significant challenges and considerable opportunities. This article examines how wound care products and services can be aligned with the strategic priorities of the 10-year plan, including three systemic shifts, in addition to value-based procurement reform and drug tariff changes. These changes will affect how wound care products already listed on drug tariff are assessed through a renewal process. This is a narrative review of policy documentation, including the 10-year health plan, NHS England procurement guidance and value-based procurement frameworks, supplemented by analysis of pilot programmes and regional exemplars. Wound care is uniquely positioned to demonstrate value across all three of the plan's strategic shifts: from hospital to community, from analogue to digital and from sickness to prevention. Value-based procurement and drug tariff reform offer practical mechanisms for realigning wound care commissioning with system outcomes. Wound care should be repositioned not as a clinical commodity but as a strategic system resource. Organisations and industry partners that can evidence system value, not just clinical efficacy, are best placed to benefit from this NHS transformation.<\/jats:p>","DOI":"10.12968\/bjcn.2026.0091","type":"journal-article","created":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T11:02:01Z","timestamp":1783767721000},"source":"Crossref","is-referenced-by-count":1,"title":["Wound care and the NHS 10-year health plan: aligning clinical innovation with system value"],"prefix":"10.12968","volume":"31","author":[{"given":"Richard H","family":"Shorney","sequence":"first","affiliation":[{"name":"Director, Real Healthcare Solutions Ltd UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Saunders","sequence":"additional","affiliation":[{"name":"Director, Med Dev Services, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"5130","reference":[{"key":"e_1_3_3_1_1","unstructured":"Department of Health and Social Care. NHS to invest in pioneering tech to drive down waiting lists. 2025. https:\/\/www.gov.uk\/government\/news\/nhs-to-invest-in-pioneering-tech-to-drive-down-waiting-lists (accessed 17 June 2026)"},{"key":"e_1_3_3_2_1","unstructured":"Department of Health and Social Care. Value-based procurement standard guidance for medical technology. 2026. https:\/\/www.gov.uk\/government\/publications\/value-based-procurement-for-medical-technology\/value-based-procurement-national-standard-guidance-for-medical-technology (accessed 17 June 2026)"},{"key":"e_1_3_3_3_1","unstructured":"Department of Health and Social Care and the Part IX Drug Tariff Industry Forum. An introduction to Part IX of the drug tariff. 2023. https:\/\/www.nhsbsa.nhs.uk\/sites\/default\/files\/2023-09\/Drug%20Tariff%20Guidance%20v1.7.pdf (accessed 17 June 2026)"},{"key":"e_1_3_3_4_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2015-009283"},{"key":"e_1_3_3_5_1","doi-asserted-by":"publisher","DOI":"10.12968\/jowc.2017.26.6.292"},{"key":"e_1_3_3_6_1","unstructured":"Heenan A. The drug tariff and wound management. WorldWideWounds. 2004. http:\/\/www.worldwidewounds.com\/2004\/march\/Heenan\/Tariff-Intro.html (accessed 17 June 2026)"},{"key":"e_1_3_3_7_1","unstructured":"National Wound Care Strategy Programme. Lower limb wound care: the economic case. 2020. https:\/\/url.uk.m.mimecastprotect.com\/s\/--z6CVm1mI1WxYJhGf4fEj6eU?domain=thehealthinnovationnetwork.co.uk (accessed 7 July 2026)"},{"key":"e_1_3_3_8_1","unstructured":"National Institute for Health and Care Excellence. NG147: leg ulcer infection \u2013 assessment and management. 2020. https:\/\/www.nice.org.uk\/guidance\/ng147 (accessed 17 June 2026)"},{"key":"e_1_3_3_9_1","unstructured":"NHS England. Fit for the future: the 10 year health plan for England. 2025a. https:\/\/www.england.nhs.uk\/long-term-plan\/ (accessed 17 June 2026)"},{"key":"e_1_3_3_10_1","unstructured":"NHS England. Neighbourhood health centre guidance for regions and integrated care boards. 2025b. https:\/\/www.england.nhs.uk\/long-read\/neighbourhood-health-centre-guidance-for-regions-and-integrated-care-boards\/ (accessed 17 June 2026)"},{"key":"e_1_3_3_11_1","unstructured":"NHS Supply Chain. Value-based procurement framework tenders: negative pressure wound care. https:\/\/url.uk.m.mimecastprotect.com\/s\/q2hYCWn2nTvM5VEtxhxfoA1s6?domain=supplychain.nhs.uk\/ (accessed 17 June 2026)"},{"key":"e_1_3_3_12_1","unstructured":"Public Policy Projects. Operationalising value-based procurement: insights from the PPP Wound Care Programme. 2025. https:\/\/publicpolicyprojects.com\/wp-content\/uploads\/2025\/07\/PPPIR_WC25-Operationalising-value-based-procurement.pdf (accessed 17 June 2026)"},{"key":"e_1_3_3_13_1","unstructured":"Robinson H. The cost effective implementation of a Wound Management Digital System (WMDS) to achieve service improvements outcome benefits and cost savings in South Warwickshire NHS Foundation Trust. 2025. Poster presentation at Wound UK. https:\/\/wounds-uk.com\/abstracts\/2024-eposter\/the-cost-effective-implementation-of-a-wound-management-digital-system-wmds-to-achieve-service-improvements-outcome-benefits-and-cost-savings-in-south-warwickshire-nhs-foundation-trust\/ (accessed 17 June 2026)"},{"key":"e_1_3_3_14_1","unstructured":"Surgical Dressing Manufacturers Association. The Supply of Wound Care and Associated Products through Part IX of the Drug Tariff. 2024. https:\/\/www.dressings.org.uk\/supply-wound-care-and-associated-products-through-part-ix-drug-tariff (accessed 17 June 2026)"},{"key":"e_1_3_3_15_1","unstructured":"Wounds UK. Best practice statement: development of a wound care formulary using clinical evidence and ensuring effective change management. 2023. https:\/\/wounds-uk.com\/best-practice-statements\/development-of-a-wound-care-formulary-using-clinical-evidence-and-ensuring-effective-change-management\/ (accessed 17 June 2026)"}],"container-title":["British Journal of Community Nursing"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.magonlinelibrary.com\/doi\/pdf\/10.12968\/bjcn.2026.0091","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T17:44:04Z","timestamp":1788371044000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.magonlinelibrary.com\/doi\/10.12968\/bjcn.2026.0091"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,1]]},"references-count":15,"journal-issue":{"issue":"Sup9","published-print":{"date-parts":[[2026,9,1]]}},"alternative-id":["10.12968\/bjcn.2026.0091"],"URL":"https:\/\/doi.org\/10.12968\/bjcn.2026.0091","relation":{},"ISSN":["1462-4753","2052-2215"],"issn-type":[{"value":"1462-4753","type":"print"},{"value":"2052-2215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,1]]}}}